Almirall completes EU regulatory procedure for antifungal Jublia

Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Oct 16, 2024 - 04:00

Almirall completes EU regulatory procedure for antifungal Jublia

Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Read the original article

Tags:

Previous Article

The science of viscous drug product filling: Pumps, pressure, and process optimi...

Parenteral Solutions in Contract Manufacturing for the Pharmaceutical Industry

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Eloxx repackages ELX-02 data in cystic fibrosis as it eyes pivotal trial

Eloxx repackages ELX-02 data in cystic fibrosis as it e...

Jun 15, 2023

STAT+: Drug industry payments to eye docs boosted Medicare spending on pricier treatments

STAT+: Drug industry payments to eye docs boosted Medic...

Sep 28, 2023

(Curcumin + doxorubicin) by Immix BioPharma for Colorec...

Dec 24, 2023